"奥山亮,辻本将晴","創薬における「創薬標的選定能力」―革新的新薬創製の競争優位に寄与する新しい能力概念とその成因―",,"イノベーション・マネジメント",,,"No. 17",,2020,Mar.
"奥山亮","サイエンス型研究開発としての創薬 ―アカデミアが果たしてきた役割の分析と産学の適切な関係性―",,,,,,,2019,June
"奥山亮","サイエンス型研究開発としての創薬 ―アカデミアが果たしてきた役割の分析と産学の適切な関係性―",,,,,,,2019,June
"奥山亮","サイエンス型研究開発としての創薬 ―アカデミアが果たしてきた役割の分析と産学の適切な関係性―",,,,,,,2019,June
"奥 山 亮,辻 本 将 晴","アカデミア創薬の背景と現状 ― 産学官各々の立場からの分析 ―",,"産学連携学",,"Vol. 13","No. 2","pp. 127-134",2017,June
"Ryo Okuyama","Importance of tacit knowledge in incremental innovation: Implications from drug discovery cases",,"Journal of Strategy and Management",,"Vol. 10","No. 1","pp. 118-130",2017,Apr.
"奥山 亮,辻本 将晴","アカデミア創薬の課題 -創薬応用研究部分の能力に関する分析-",,"医療と社会",,"Vol. 27","No. 2","pp. 237-250",2017,Jan.
"Ryo Okuyama","The types of scientific information and technologies acquired from university-industry relationships in the Japanese pharmaceutical industry - An empirical study from 1980 to 2012",,"International Journal of Technology Transfer and Commercialisation",,"Vol. 13","No. 3/4","pp. 178-191",2016,Apr.
"Ryo Okuyama","Acquisition of drug candidates in New Drug Development in Japan","Portland International Center for Management of Engineering and Technology (PICMET) ’14",,,,,,2014,July
"Ryo Okuyama","University-Industry Collaboration in Drug Discovery in Japan: An Empirical Analysis over Thirty Years","Proceedings of Portland International Center for Management of Engineering and Technology (PICMET) ’13",,,,,,2013,July
"奥山亮","革新的創薬研究に効果的な共同研究マネジメント -国産初の抗体医薬品アクテムラの事例分析-","日本MOT学会 第２回年次研究発表会",,,,,,2011,Mar.
"奥山亮","新薬研究開発の成功に影響を与える要因の分析 ?アンジオテンシンII受容体拮抗薬研究開発の事例分析-","研究・技術計画学会 第２５回年次学術集会",,,,,,2010,Oct.